In this article, Mitch Beaumont, Prashanth Prasad, Ulrica Sehlstedt and Mandeep Dhillon, Arthur D. Little, introduce a framework to guide analogue-native companies in the use of levers to manage the transition to digital.
In this feature, Medicom, a Phillips-Medisize company, looks at the potential of smart devices & connected health services within the pharma sector and how companies can use already available technologies to make the transition as smooth as possible
The team behind PuroVaso saw an opportunity to design an entirely new solution for moving and storing that was better suited to modern manufacturing processes. Here, they tell us more…
As the manufacture of biologics takes on increased significance in the pharmaceutical sector, it’s clear to see why GE Healthcare’s KUBio system is growing in popularity. Lu Rahman paid a visit to the company facility in Uppsala to find out more…
In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D.
Independent consulting group, NDA, has announced its findings from its fifth annual comparison of drug approvals in Europe and the US in preparation for this year’s DIA Europe in Basel, Switzerland.
The BIA and business intelligence group, Informa, have released their first quarterly financing update on the biotech sector, showing that venture capital financing and follow on financings on the public markets are off to a solid start
Here, Dr Neil Polwart, Novarum founder and BBI group head of mobile, goes into greater detail about how digital technologies will herald a new era for pharma.
With recent plans announced by the UK’s prime minister to remain part of the EMA, which would be favourable for many in the pharma industry, I will look at these developments as well as how they will impact industry and the reactions from leaders
According to data and analytics company, GlobalData, pharmaceutical sales within the age-related macular degeneration (AMD) markets will soar to $11.5 billion by the year 2026.
